FDA approves new nasal spray for migraines

FDA approves new nasal spray for migraines – CBS News


Watch CBS News



The Food and Drug Administration has approved a new nasal spray from Pfizer to treat migraines. Zavzpret is expected to be available in July.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


Add a Comment

Your email address will not be published. Required fields are marked *